Suchergebnisse - "Ofran, Yishai"

PubPharm (141)

101

Azacitidine-lenalidomide (ViLen) combination yields a high response rate in higher risk myelodysplastic syndromes (MDS)—ViLen-01 protocol

enthalten in: Annals of hematology | 2016

von Mittelman, M. | Filanovsky, K. | Ofran, Y. | +9

102

Azacitidine-lenalidomide (ViLen) combination yields a high response rate in higher risk myelodysplastic syndromes (MDS)—ViLen-01 protocol

enthalten in: Annals of hematology | 2016

von Mittelman, M. | Filanovsky, K. | Ofran, Y. | +9

103

Azacitidine-lenalidomide (ViLen) combination yields a high response rate in higher risk myelodysplastic syndromes (MDS)—ViLen-01 protocol

enthalten in: Annals of hematology | 2016

von Mittelman, M. | Filanovsky, K. | Ofran, Y. | +9

104

How I treat acute myeloid leukemia presenting with preexisting comorbidities

enthalten in: Blood | 2016

von Ofran, Y. | Tallman, M. | Rowe, J.

105

Adult Nephrotic Syndrome after Hematopoietic Stem Cell Transplantation : Renal Pathology is the Best Predictor of Response to Therapy

enthalten in: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation | 2016

von Beyar-Katz, O. | Davila, E. | Zuckerman, T. | +7

106

Is the D14 bone marrow in acute myeloid leukemia still the gold standard?

enthalten in: Current opinion in hematology | 2016

von Ofran, Y.

107

Is the D14 bone marrow in acute myeloid leukemia still the gold standard?

enthalten in: Current opinion in hematology | 2016

von Ofran, Y.

108

How I treat acute myeloid leukemia presenting with preexisting comorbidities

enthalten in: Blood | 2016

von Ofran, Y. | Tallman, M. | Rowe, J.

109

BCR-ABL (Ph)-like acute leukemia—Pathogenesis, diagnosis and therapeutic options

enthalten in: Blood reviews | 2016

von Ofran, Y. | Izraeli, S.

110

Prospective comparison of early bone marrow evaluation on day 5 versus day 14 of the "3 + 7" induction regimen for acute myeloid leukemia

enthalten in: American journal of hematology | 2015

von Ofran, Y. | Leiba, R. | Ganzel, C. | +15